Enoxaparin ppx superior to heparin in most outcomes per 2014 Cochrane review including risk of DVT (OR 0.77) and major bleeding (OR 0.43) although no difference in mortality. https://t.co/DdCcfRlM2E https://t.co/somWNfVbpa
@oleschri @CochraneAT Kein Bemmerl triffts echt super :) Deshalb wirds ja auch zur Thromboseprophylaxe gespritzt :) Und da gibts auch mehr Evidenz. https://t.co/TrEEgAGYEE
@techpriest You mean you don't enjoy sitting through the annual VTE audit? Unfortunately these audits often ignore what the purpose of these interventions are and it becomes as you say box ticking for training. https://t.co/FA5o8apOB0 https://t.co/sKGQ2GTJ
RT @tony_breu: @DrTobyGilbert @Jediprude @laxswamy Depending on the meta-analysis you use, the NNT for PE ranges from 243-769. This is for…
RT @tony_breu: @DrTobyGilbert @Jediprude @laxswamy Depending on the meta-analysis you use, the NNT for PE ranges from 243-769. This is for…
RT @tony_breu: @DrTobyGilbert @Jediprude @laxswamy Depending on the meta-analysis you use, the NNT for PE ranges from 243-769. This is for…
@DrTobyGilbert @Jediprude @laxswamy Depending on the meta-analysis you use, the NNT for PE ranges from 243-769. This is for high risk patients. https://t.co/w6cze3L3PD https://t.co/Rh7JZeM1kg https://t.co/IXIKunPbFj
New from #CSO_Scotland https://t.co/sMhxnPj9zF Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)
@Dr_JSA Btw at least there is *some* evidence for flu vaccines unlike -Contact precautions/plastic gowns https://t.co/odwP8QrXnn -Bare below the elbow https://t.co/HsieCUePyW -Routinely changing IV cannulas https://t.co/1enjWtIoi3 -VTE prophylaxis medi
@bhwords @dan26wales @danfurmedge This 2014 Cochrane systematic review & meta-analysis (gold standard evidence) suggests in acutely ill medical patients (not surgical; excl MI & stroke) there is no overall mortality reduction. It’s a good question.
@laxswamy @rbganatra When excluding MI/CVA patients, not clear it reduces PE. Even if did, event rates well <1% suggests NNT in 1000s. https://t.co/43Lbvy9Qwr https://t.co/N1t6EPbsHR
Heparin for prevention of VTE in acutely medically ill (exclud stroke & MI) @CochranePVD update published http://t.co/HpCiQQMk56 @VSGBI
"@ernestob: Heparina para prevención de TVP en patología médica aguda (no ACV ni IAM) [Cochrane] http://t.co/cRqPiqn7N4"
Heparina para prevención de TVP en patología médica aguda (no ACV ni IAM) [Cochrane] http://t.co/by4MgEEvZ2
Heparina para prevención de TVP en patología médica aguda (no ACV ni IAM) [Cochrane] http://t.co/by4MgEEvZ2